Is clinicopathological distinction of mucosa-associated lymphoid tissue lymphoma from Waldenström macroglobulinemia essential in MYD88 L265P mutation-positive cases?
We gratefully acknowledge Dr. Shinichiro Okamoto of Division of Hematology, Department of Medicine, Keio University School of Medicine, for providing useful suggestions. This work was supported in part by a grant from the Japan Leukemia Research Fund (to K.K.).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
Written informed consent was obtained from the patients for publication.